Pegasys Drug Interactions: What to Avoid and What to Tell Your Doctor

Pegasys (Peginterferon Alfa-2a) can interact with many other medications, some in serious or even life-threatening ways. Because it affects the immune system, inhibits a liver enzyme (CYP1A2), and affects blood cell production, it touches a wide range of drug pathways. Here's what you need to know before starting Pegasys — and what to tell your doctor about.

Important: Always provide your doctor and pharmacist with a complete list of everything you take — prescription medications, over-the-counter drugs, vitamins, supplements, and herbal products. Never start or stop a medication without consulting your healthcare provider.

How Pegasys Causes Drug Interactions

Pegasys causes drug interactions through two primary mechanisms:

1. CYP1A2 inhibition: Pegasys inhibits CYP1A2, a liver enzyme responsible for metabolizing many drugs. When Pegasys inhibits this enzyme, drugs that rely on CYP1A2 for breakdown build up to higher-than-intended levels in the blood, increasing their effects and toxicity risk.
2. Pharmacodynamic synergism: Combining Pegasys with other drugs that cause similar effects (like suppressing white blood cells) can compound those effects to dangerous levels.

Contraindicated Combinations: Do Not Use Together

• Fezolinetant (Veozah): Pegasys is contraindicated with fezolinetant, a medication for hot flashes. CYP1A2 inhibition by Pegasys significantly raises fezolinetant blood levels, increasing risk of serious toxicity. Do not use together.

Severe Interactions: Avoid or Use With Extreme Caution

• Didanosine (ddI): When combined with Pegasys (especially with ribavirin), there is a significantly increased risk of hepatic failure, peripheral neuropathy, and pancreatitis. Avoid this combination.
• Zidovudine (AZT) + Ribavirin: The combination of Pegasys + ribavirin + zidovudine is associated with severe neutropenia and severe anemia. Avoid in patients receiving zidovudine-containing regimens.
• Deferiprone (Ferriprox): Pharmacodynamic synergism increases risk of severe neutropenia or agranulocytosis. Avoid combination; if unavoidable, monitor absolute neutrophil count very closely.
• Alosetron (Lotronex): CYP1A2 inhibition increases alosetron levels, raising risk of serious colonic ischemia. Avoid if possible.

Interactions Requiring Monitoring or Dose Adjustment

• Theophylline: Pegasys increases theophylline blood levels by about 25% (CYP1A2 inhibition). If you take theophylline for asthma or COPD, your theophylline levels must be monitored and your dose may need to be reduced.
• Tizanidine (Zanaflex): CYP1A2 inhibition raises tizanidine levels, increasing risk of low blood pressure and excessive sedation. Use with extreme caution.
• Clozapine (Clozaril): CYP1A2 inhibition can increase clozapine levels, raising risk of agranulocytosis and seizures. Requires careful monitoring.
• Duloxetine (Cymbalta): CYP1A2 inhibition increases duloxetine exposure. Monitor for increased duloxetine side effects (nausea, dizziness, serotonin symptoms).
• Clomipramine: CYP1A2 inhibition can increase levels of this tricyclic antidepressant; monitor for anticholinergic effects and cardiac toxicity.
• Ropeginterferon alfa-2b (BESREMi): Additive myelosuppression; these two interferon drugs should never be used simultaneously.
• Bendamustine: CYP1A2 substrate; increased bendamustine exposure possible; use with caution in oncology settings.

Important Interactions for HIV/Hepatitis Coinfected Patients

Patients coinfected with HIV/HCV who have cirrhosis and are receiving HAART (highly active antiretroviral therapy) are at increased risk of hepatic decompensation when treated with Pegasys. This risk is particularly associated with NRTIs including stavudine, didanosine, abacavir, zidovudine, and lamivudine. In one study, 11% of cirrhotic HIV/HCV coinfected patients on HAART who received Pegasys developed hepatic decompensation. Close monitoring of liver function is essential in this population.

Food and Substance Interactions

• Alcohol: Avoid alcohol while taking Pegasys. Alcohol can worsen liver disease (the very condition Pegasys is often treating) and may worsen side effects including depression and drowsiness.
• Herbal supplements: Some herbal products can be hepatotoxic (harmful to the liver) or affect immune function. Always inform your doctor of any supplements you take.

Ribavirin Interactions: An Important Note

Pegasys is often combined with ribavirin for hepatitis C treatment. When using this combination, additional drug interactions specific to ribavirin also apply — including serious birth defect risk (both partners must use contraception during and for 6 months after treatment). Ribavirin is contraindicated in pregnancy and with didanosine.

What to Tell Your Doctor Before Starting Pegasys

Tell your doctor about every medication you take, including theophylline, any antidepressants, antipsychotics (especially clozapine), HIV medications, iron chelators, and any herbal supplements. Your doctor should conduct a complete drug interaction review before prescribing Pegasys. For a broader overview of safety, see our guide on Pegasys side effects and when to call your doctor.